Trial intelligence / Profile preview

Prophylactic nimodipine for hearing preservation after vestibular schwannoma surgery

DRKS00019107Phase 3Completed

Sponsor
University Hospital Halle (Saale)
Start
May 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of nimodipine in acoustic neuroma and Benign neoplasm of cranial nerve (2 arms), sponsored by University Hospital Halle (Saale). Started May 2020; status: completed.

02

Drugs

nimodipine
03

Conditions

acoustic neuromaBenign neoplasm of cranial nerve

Beyond the preview

Go deeper on DRKS00019107.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00019107.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call